Catalyst Wire Dossier Catalyst Wire Dossier

recombinant Bet v 1

Bet v 1 allergen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant Bet v 1, covering 2015-12-08 to 2015-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments

See pricing